Megías-Vericat, Juan Eduardo http://orcid.org/0000-0002-0369-5341
Solana-Altabella, Antonio
Ballesta-López, Octavio http://orcid.org/0000-0002-5444-5836
Martínez-Cuadrón, David
Montesinos, Pau http://orcid.org/0000-0002-3275-5593
Funding for this research was provided by:
Instituto de Salud Carlos III (PI16/00665)
Fundación para la Investigación del Hospital Universitari La Fe (2019/052-1)
Article History
Received: 4 May 2020
Accepted: 13 July 2020
First Online: 18 July 2020
Compliance with ethical standards
:
: Pau Montesinos reports these potential conflicts of interest, AbbVie: advisory board, speakers bureau, research support; Astellas: research support, consultant, speakers bureau, advisory board; Agios: consultant; Tolero Pharmaceutical: consultant; Glycomimetics: consultant; Forma Therapeutics: consultant; Celgene: research support, consultant, speakers bureau, advisory board; Daiichi Sankyo: research support, consultant, speakers bureau, advisory board; Incyte: speakers bureau, advisory board; Janssen: research support, speakers bureau, advisory board; Karyopharm: research support, advisory board; Novartis: research support, speakers bureau, advisory board; Pfizer: research support, speakers bureau, advisory board; Teva: research support, speakers bureau, advisory board. The rest of authors declare that there are no competing financial interests in relation to the work described.